These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 19697455)

  • 1. Perihepatic adipose tissue thickness.
    Riley T
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):252. PubMed ID: 19697455
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic and perihepatic radiolucencies.
    Mindelzun R; McCort JJ
    Radiol Clin North Am; 1980 Aug; 18(2):221-38. PubMed ID: 7208861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasonography to quantify hepatic fat content: validation by 1H magnetic resonance spectroscopy.
    Edens MA; van Ooijen PM; Post WJ; Haagmans MJ; Kristanto W; Sijens PE; van der Jagt EJ; Stolk RP
    Obesity (Silver Spring); 2009 Dec; 17(12):2239-44. PubMed ID: 19461588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of hepatic steatosis after pancreatoduodenectomy.
    Nomura R; Ishizaki Y; Suzuki K; Kawasaki S
    AJR Am J Roentgenol; 2007 Dec; 189(6):1484-8. PubMed ID: 18029889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doppler waveforms of the hepatic veins in children with diffuse fatty infiltration of the liver.
    Uzun H; Yazici B; Erdogmus B; Kocabay K; Buyukkaya R; Buyukkaya A; Yazgan O
    Eur J Radiol; 2009 Sep; 71(3):552-6. PubMed ID: 18824318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial Comment: Multiparametric Ultrasound Assessment of Hepatic Fat Fraction in a Real-World Population.
    Calliada F
    AJR Am J Roentgenol; 2024 Jun; 222(6):e2431226. PubMed ID: 38568040
    [No Abstract]   [Full Text] [Related]  

  • 7. Fatty liver--based identification of two distinct hypertriglyceridemic subgroups in familial combined hyperlipidemia.
    Brouwers MC; van Greevenbroek MM; Bilderbeek-Beckers MA; Robertus-Teunissen MG; van der Kallen CJ; Stehouwer CD; de Bruin TW
    Metabolism; 2007 Oct; 56(10):1311-7. PubMed ID: 17884438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty liver is an integral feature of familial combined hyperlipidaemia: relationship with fat distribution and plasma lipids.
    Brouwers MC; Bilderbeek-Beckers MA; Georgieva AM; van der Kallen CJ; van Greevenbroek MM; de Bruin TW
    Clin Sci (Lond); 2007 Jan; 112(2):123-30. PubMed ID: 16958621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive tests for liver fibrosis: encouraging or discouraging results?
    Burroughs AK; Cholongitas E
    J Hepatol; 2007 May; 46(5):751-5. PubMed ID: 17383047
    [No Abstract]   [Full Text] [Related]  

  • 10. Gamut of focal fatty lesions in the liver: imaging manifestations with emphasis on magnetic resonance imaging.
    Fasih N; Shanbhogue AK; Thipphavong S; Surabhi VR; Papadatos D; Marginean C
    Curr Probl Diagn Radiol; 2010; 39(4):137-51. PubMed ID: 20510752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invited commentary.
    Sirlin CB
    Radiographics; 2009; 29(5):1277-80. PubMed ID: 19764109
    [No Abstract]   [Full Text] [Related]  

  • 12. [The use of Meta-analysis in the evaluation on diagnostic tests].
    Liu YX; Wang JZ; Pang CK; Liu JP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Apr; 26(4):294-6. PubMed ID: 15941542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation between skinfold thickness and ultrasonography in the study of subcutaneous adipose tissue in females].
    Cataldo MG; Brancato D; Brancato G; Verga S; Buscemi S; Licata G
    Ann Ital Med Int; 1997; 12(1):15-9. PubMed ID: 9409947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sonographic hepatic-renal ratio as indicator of hepatic steatosis: comparison with (1)H magnetic resonance spectroscopy.
    Mancini M; Prinster A; Annuzzi G; Liuzzi R; Giacco R; Medagli C; Cremone M; Clemente G; Maurea S; Riccardi G; Rivellese AA; Salvatore M
    Metabolism; 2009 Dec; 58(12):1724-30. PubMed ID: 19716568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clues from the carotids: an appraisal of cardiovascular disease risk in non-alcoholic fatty liver disease.
    Chitturi S; Farrell GC
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1315-7. PubMed ID: 19702897
    [No Abstract]   [Full Text] [Related]  

  • 16. Contrast-enhanced ultrasound: emerging modality for liver lesion characterization.
    Ong YY; Gibson RN
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1465-6. PubMed ID: 19120843
    [No Abstract]   [Full Text] [Related]  

  • 17. Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance.
    Kelley DE; McKolanis TM; Hegazi RA; Kuller LH; Kalhan SC
    Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E906-16. PubMed ID: 12959938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sonographic measurement of the thickness of subcutaneous tissues in nonalcoholic fatty liver disease versus other chronic liver diseases.
    Riley TR; Bruno MA
    J Clin Ultrasound; 2005 Dec; 33(9):439-41. PubMed ID: 16281268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between serum leptin and fatty liver in Japanese male adolescent university students.
    Tobe K; Ogura T; Tsukamoto C; Imai A; Matsuura K; Iwasaki Y; Shimomura H; Higashi T; Tsuji T
    Am J Gastroenterol; 1999 Nov; 94(11):3328-35. PubMed ID: 10566739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of hepatic steatosis and fatty sparing.
    Karcaaltincaba M; Akhan O
    Eur J Radiol; 2007 Jan; 61(1):33-43. PubMed ID: 17118603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.